Shares Held (Direct Ownership) 1.5M
n/a 3M change
n/a 12M change
Total Value Held N/A

Tien-Li Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
BUY
Open market or private purchase
$264,672 $16.0 p/Share
16,542 Added 1.09%
1,496,175 Common Stock
Feb 14 2025
BUY
Conversion of derivative security
-
41,303 Added 2.72%
1,479,633 Common Stock

Also insider at

VCKA
Vickers Vantage Corp. I Financial Services
TL

Tien Li Lee

Chief Executive Officer
Palo Alto, CA

Track Institutional and Insider Activities on AARD

Follow Aardvark Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AARD shares.

Notify only if

Insider Trading

Get notified when an Aardvark Therapeutics, Inc. insider buys or sells AARD shares.

Notify only if

News

Receive news related to Aardvark Therapeutics, Inc.

Track Activities on AARD